Tacrolimus

Product NDC
70518-2593
11-digit product format
705182593
Labeler code
70518
Product ID
70518-2593_ca7776bf-3b7a-7289-e053-2995a90a6591
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Tacrolimus
Dosage form
CAPSULE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA065461
Marketing category
ANDA
Marketing start
2020-03-03
Marketing end
0000-00-00
Substance
TACROLIMUS
Active strength
1 mg/1
Pharmacologic classes
Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2593-02023-03-10C16284748780-1f386c64a-25ee-0266-e053-dadaa90a7c1accb7432c-4e75-4e2e-af05-d7970191fc35
70518-2593-02023-01-30C16284748780-1f386c64a-25ee-0266-e053-dadaa90a7c1accb7432c-4e75-4e2e-af05-d7970191fc35

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2593-07051825930030 CAPSULE in 1 BLISTER PACK (70518-2593-0) 30 capsule2020-03-030000-00-00NoNoCurrent